Posts Tagged ‘vardenafil’

VIVUS Initiates Second Pivotal Phase 3 Trial Of Avanafil For Treatment Of Erectile Dysfunction

Posted by poster on February 14th, 2009 under Uncategorized Tags: , , , , , ,  •  Comments Off

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated a second pivotal Phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting,

No Need To Whisper: Talking And Treating Erectile Dysfunction

Posted by poster on February 7th, 2009 under Uncategorized Tags: , , , , , , ,  •  Comments Off

The conversation about male sexual dysfunction has grown from a whisper to a roar. From Bob Dole to Mike Ditka, erectile dysfunction, or ED, is no longer hush-hush as more men are talking more openly. Non-stop commercials convey help in the bedroom is just a prescription away. Generic synthroid pills no prescription

Pharmacy Chain Allows Men To Get Erectile Dysfunction Drugs Without Visiting Their GP, UK

Posted by poster on December 31st, 2008 under Uncategorized Tags: , , , , , ,  •  Comments Off

A new service which allows men to get erectile dysfunction drugs legitimately without having to visit their GP for a prescription has been launched.
The new service - a UK first - is being launched by Lloydspharmacy in partnership with sexual health experts Dr Thom, The service offers online diagnosis of erectile problems

Study Shows PDE5 Inhibitor More Effective When Used On-Demand In Erectile Dysfunction

Posted by poster on March 26th, 2008 under Uncategorized Tags: , ,  •  Comments Off

European Urology, the official journal of the European Association of Urology will be featuring the article ‘Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy’ by F. Montorsi et al.in the October issue, showing for the first time that vardenafil, a PDE5 inhibitor, is